首页> 外文期刊>Polish Journal of Radiology >Verification of breast microcalcifications clusters in stereotactic mammotome biopsy under the guidance of digital mammography
【24h】

Verification of breast microcalcifications clusters in stereotactic mammotome biopsy under the guidance of digital mammography

机译:在数字化乳腺X线摄影术的指导下进行立体定向乳腺切除术活检中的乳房微钙化簇的验证

获取原文
           

摘要

Background: The aim of study is to determine the usefulness of stereotactic mammotome biopsy (SMB) under the guidance of digital mammography in the verification of clusters of breast microcalcifications BI-RADS 3-5 categories without accompanying masses. Material/Methods: Material included 97 patients with 108 clusters of microcalcifications BI-RADS 3-5 categories without accompanying masses. In all cases verification in SMB was ordered. Procedure was performed in 98 clusters. In 10 clusters using of SMB was not possible and then surgical biopsy was performed. Results: In 98 from among clusters with SMB performed, pathological examination proved presence of only benign lesions in 86 cases, an atypical lesion in 2 cases, malignant lesions in 10 cases (including 8 preinvasive lesions). Most (97.2%) clusters of microcalcifications, classified as BI-RADS 3 corresponded to benign lesions. In BI-RADS 4 group lesions were benign in 72.7%, atypical in 4.5%, malignant in 22.7%. In BI-RADS 5 group most (80%) lesions were malignant. Conclusions: It was found, that SMB can be used as a safe and reliable method of verification of the nature of clusters of breast microcalcifications without accompanying masses in all cases of BI-RADS 4 and 5 categories and in selected cases of BI-RADS 3 category. SMB enables avoiding surgery in a considerable number of patients with microcalcifications of BI-RADS 4 category.
机译:背景:本研究的目的是确定在乳腺X线摄影术(BI-RADS 3-5类,无伴随肿块)的数字化乳腺X线摄影术指导下进行立体定向乳腺穿刺活检(SMB)的有效性。材料/方法:材料包括97例患者,其中108例为微簇钙化BI-RADS 3-5类,无伴发肿块。在所有情况下,都要求在SMB中进行验证。该程序在98个集群中执行。在10个集群中不可能使用SMB,然后进行手术活检。结果:在进行过SMB的群集中的98个中,病理检查证实仅存在良性病变86例,非典型病变2例,恶性病变10例(包括8个浸润前病变)。归为BI-RADS 3的大多数微钙化簇(97.2%)对应于良性病变。在BI-RADS中,4组病变为良性,占72.7%,非典型性为4.5%,恶性为22.7%。在BI-RADS 5组中,大多数(80%)病变是恶性的。结论:发现在所有BI-RADS 4和5类病例以及部分BI-RADS 3病例中,SMB均可作为一种安全可靠的方法来验证乳房微钙化簇的性质,而无伴随肿块类别。 SMB可以避免大量BI-RADS 4类钙化患者的手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号